- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vita 34 AG (V3VGn)Vita 34 AG stock price live, this page displays F V3VGn stock exchange data. View the V3VGn premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vita 34 AG real time stock price chart below.
What Is the Vita 34 AG Stock Price Today?
The Vita 34 AG stock price today is 4.040.
What Is the Stock Symbol for Vita 34 AG?
The stock symbol for Vita 34 AG is "V3VGn."
What Stock Exchange Does Vita 34 AG Trade On?
Vita 34 AG is listed and trades on the Frankfurt stock exchange.
Is Vita 34 AG a Good Stock to Buy?
Determining whether Vita 34 AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the V3VGn quote. (ISIN: DE000A0BL849)
What Is the Vita 34 AG Stock Price Today?
The Vita 34 AG stock price today is 4.040.
What Is the Stock Symbol for Vita 34 AG?
The stock symbol for Vita 34 AG is "V3VGn."
What Stock Exchange Does Vita 34 AG Trade On?
Vita 34 AG is listed and trades on the Frankfurt stock exchange.
Is Vita 34 AG a Good Stock to Buy?
Determining whether Vita 34 AG—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the V3VGn quote. (ISIN: DE000A0BL849)
4.040
-0.040(-0.98%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.000
4.160
52 wk Range
3.690
5.900
V3VGn Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
Unusual trading volume
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.0004.160
52 wk Range
3.6905.900
Key Statistics
Edit
Fair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockV3VGn Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
6.300
Upside
+57.500%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Valuation implies a strong free cash flow yield
Vita 34 AG Company Profile
VITA 34 AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
Compare V3VGn to Peers and Sector
Metrics to compare | V3VGn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipV3VGnPeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.3x | 1.5x | −0.6x | |
PEG Ratio | 0.25 | 0.02 | 0.00 | |
Price/Book | 2.9x | 0.9x | 2.6x | |
Price / LTM Sales | 0.9x | 0.3x | 3.2x | |
Upside (Analyst Target) | 55.9% | 68.2% | 44.6% | |
Fair Value Upside | Unlock | 23.5% | 7.3% | Unlock |
Analysts' Recommendations
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.300
(+55.94% Upside)
FAQ
What Is the Vita 34 AG (V3VGn) Stock Price Today?
The Vita 34 AG stock price today is 4.04.
What Stock Exchange Does Vita 34 AG Trade On?
Vita 34 AG is listed and trades on the Xetra stock exchange.
What Is the Stock Symbol for Vita 34 AG?
The stock symbol for Vita 34 AG is "V3VGn."
What Is the Vita 34 AG Market Cap?
As of today, Vita 34 AG market cap is 70.42M.
What is Vita 34 AG Earnings Per Share?
The Vita 34 AG EPS is 0.145.
From a Technical Analysis Perspective, Is V3VGn a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.